	US 12,239,695 B2
	Composition comprising thrombin-treated stem cell-derived exosome for treating skin wound
Yun Sil Chang, Seoul (KR); Won Soon Park, Seoul (KR); Dong Kyung Sung, Seoul (KR); and So Yoon Ahn, Seoul (KR)
Assigned to SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, Seoul (KR)
Appl. No. 16/314,725
Filed by SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, Seoul (KR)
PCT Filed Jun. 27, 2017, PCT No. PCT/KR2017/006776 § 371(c)(1), (2) Date Jan. 2, 2019, PCT Pub. No. WO2018/004237, PCT Pub. Date Jan. 4, 2018.
Claims priority of application No. 10-2016-0083703 (KR), filed on Jul. 1, 2016; and application No. 10-2017-0080366 (KR), filed on Jun. 26, 2017.
Prior Publication US 2019/0314469 A1, Oct. 17, 2019
Int. Cl. A61K 38/48 (2006.01); A61K 9/12 (2006.01); A61K 9/70 (2006.01); A61K 35/28 (2015.01); A61P 17/02 (2006.01)

CPC A61K 38/4833 (2013.01) [A61K 9/12 (2013.01); A61K 9/70 (2013.01); A61K 35/28 (2013.01); A61P 17/02 (2018.01)]

7 Claims

1. A method of treating skin wound, comprising:

administering to a subject in need thereof an effective amount of exosomes derived from thrombin-treated stem cells.